A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of amyloid B component, also known as amyloid beta or Aß, in a clinical specimen, using a chemiluminescent immunoassay method. It i...
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of amyloid A component in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of the apolipoprotein, serum amyloid A in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of amyloid A component in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of amyloid P component in a clinical specimen.
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to diagnose, monitor or predict hereditary cerebral haemorrhage with amyloidosis (Dutch type), associated with mutations in the gene encoding the amy...